01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

Wanted: People Willing to Get Sick to Find Coronavirus Vaccine March 19, 2020 – Posted in: Open Orphan (ORPH)

British lab is recruiting volunteers for study it says could speed development of Covid-19 vaccine By Denise Roland March 19, 2020 7:00 am ET Thousands of people have volunteered to be infected in the hope of finding a vaccine for the new coronavirus.  hVIVO, a clinical research group in London, has attracted more than 20,000 volunteers willing to be infected with tamer relatives of the virus that causes Covid-19 in exchange for a fee of…

Continue reading

Open Orphan #ORPH – Appointment of new Director – Posted in: Open Orphan (ORPH)

Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services , is pleased to announce, further to its announcement of 13 February 2020, the appointment to the board of Leo Toole as Chief Financial Officer. Leo Toole brings over 20 years’ experience in senior finance roles in Pharmaceuticals, Medical Technology and FMCG sectors. He…

Continue reading

Open Orphan #ORPH presents at ShareSoc Growth Company Seminar, Manchester February 21, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, and has Europe’s only 24 bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital London, is pleased to announce that the Company will be attending and presenting at the ShareSoc Growth Company Seminar on February 25, 2020 at DoubleTree by Hilton Hotel, One Piccadilly Place, 1 Auburn Street,…

Continue reading

Open Orphan #ORPH – Appointment of Group Chief Financial Officer February 13, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, and has Europe’s only 24 bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital London, is pleased to announce the appointment of Leo Toole to the role of Group Chief Financial Officer with immediate effect. Leo was previously Interim Chief Financial…

Continue reading

Open Orphan #ORPH presents at Shares Growth and Invention Forum, London February 7, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that the Company will be attending and presenting at the Shares Growth and Invention Forum on February 11, 2020 at Business Design Centre, London N1, London, N1 0QH. Cathal will be presenting at 15:30 in the Babbage Room. Investors are able to register to attend…

Continue reading

Open Orphan #ORPH – Upcoming Investor Events February 6, 2020 – Posted in: Open Orphan (ORPH)

Open Orphan (ORPH), the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is  pleased to announce that the Company will be attending and presenting at a series of investor events from the 11th February to 26th March 2020. Cathal Friel, Open Orphan’s Executive Chairman, or Trevor Phillips, CEO, will be in attendance for all…

Continue reading